01 1Medilux Laboratories
01 1TRAZODONE HYDROCHLORIDE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-04-14
Pay. Date : 2024-09-11
DMF Number : 39530
Submission : 2024-02-13
Status : Active
Type : II
20
Medilux Laboratories Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is TRAZODONE HYDROCHLORIDE USP, with a corresponding US DMF Number 39530.
Remarkably, this DMF maintains an Active status since its submission on February 13, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 14, 2025, and payment made on September 11, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
